SIX1 and prostate cancer: Thus, the present study first analyzed the SIX1 expression pattern in liver, colon, breast, ovarian, kidney, lung, thyroid, and prostate cancers using cDNA arrays; the array represented tissues from 3 non-malignant samples and 9 tumor samples of 8 different cancer types.